Surgery Partners, Inc. Forecast, price target & analysts
Surgery Partners, Inc. Target price 2026 - Analyst rating & recommendation
Surgery Partners, Inc. Classifications & Recommendation
Surgery Partners, Inc. Price Target
| Target Price | $19.38 |
| Price | $14.41 |
| Potential |
34.49%
register free of charge
|
| Number of Estimates | 13 |
|
13 Analysts have issued a price target Surgery Partners, Inc. 2027 .
The average Surgery Partners, Inc. target price is $19.38.
This is
34.49%
register free of charge
$25.20
74.88%
register free of charge
$14.14
1.87%
register free of charge
|
|
| A rating was issued by 18 analysts: 14 Analysts recommend Surgery Partners, Inc. to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Surgery Partners, Inc. stock has an average upside potential 2027 of
34.49%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2029
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 3.31 | 3.49 |
| 6.24% | 5.45% | |
| EBITDA Margin | 19.81% | 15.22% |
| 1.58% | 23.18% | |
| Net Margin | -2.35% | 1.91% |
| 56.38% | 181.12% |
14 Analysts have issued a sales forecast Surgery Partners, Inc. 2026 . The average Surgery Partners, Inc. sales estimate is
This results in the following potential growth metrics:
14 Analysts have issued an Surgery Partners, Inc. EBITDA forecast 2026. The average Surgery Partners, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
14 Surgery Partners, Inc. Analysts have issued a net profit forecast 2026. The average Surgery Partners, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2029
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.61 | 0.51 |
| 54.14% | 183.61% | |
| P/E | 28.92 | |
| EV/Sales | 1.56 |
14 Analysts have issued a Surgery Partners, Inc. forecast for earnings per share. The average Surgery Partners, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Surgery Partners, Inc....
Current Surgery Partners, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| TD Cowen |
Locked
➜
Locked
|
Locked | Sep 18 2026 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Sep 14 2026 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Aug 11 2026 |
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Aug 11 2026 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Aug 11 2026 |
| UBS |
Locked
➜
Locked
|
Locked | Mar 05 2026 |
| Mizuho |
Locked
➜
Locked
|
Locked | Mar 05 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
TD Cowen:
Locked
➜
Locked
|
Sep 18 2026 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Sep 14 2026 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Aug 11 2026 |
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Aug 11 2026 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Aug 11 2026 |
|
Locked
UBS:
Locked
➜
Locked
|
Mar 05 2026 |
|
Locked
Mizuho:
Locked
➜
Locked
|
Mar 05 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
